Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.36 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.34 |
| ▸ | XDH | P47989 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | P4HB | P07237 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | FASN | P49327 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6282046 | 0.90 | SLC5A2 (0.46) | EPHX2SLC5A2POLB | |
| SCHEMBL6282017 | 0.79 | TYR (0.51) | SLC5A2POLBGAA | |
| SCHEMBL7154852 | 0.75 | SLC5A2 (0.45) | EPHX2SLC5A2POLB | |
| SCHEMBL3642166 | 0.75 | SLC5A2 (0.45) | EPHX2SLC5A2POLB | |
| SCHEMBL20643537 | 0.75 | SLC5A2 (0.45) | EPHX2SLC5A2POLB | |
| SCHEMBL15671094 | 0.75 | SLC5A2 (0.45) | EPHX2SLC5A2POLB | |
| SCHEMBL7133576 | 0.75 | SLC5A2 (0.45) | EPHX2SLC5A2POLB | |
| SCHEMBL12866146 | 0.74 | FUCA1 (0.37) | CA12CA9 | |
| SCHEMBL10305226 | 0.73 | TYR (0.46) | SLC5A2POLBGAA | |
| SCHEMBL12500750 | 0.73 | TYR (0.46) | SLC5A2POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958395-B2 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by Diels-Alder reaction | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2005-10-25 | — | — | US | claimed |
| US-20040059101-A1 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by diels-alder reaction | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2004-03-25 | — | — | US | claimed |
| EP-1313750-A1 | METHOD FOR PRODUCING WATER-SOLUBLE SACCHARIDE CONJUGATES AND SACCHARIDE MIMETICS BY DIELS-ALDER REACTION | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2003-05-28 | — | — | EP | claimed |
| WO-2002016378-A1 | METHOD FOR PRODUCING WATER-SOLUBLE SACCHARIDE CONJUGATES AND SACCHARIDE MIMETICS BY DIELS-ALDER REACTION | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2002-02-28 | — | — | WO | claimed |
| US-6958395-B2 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by Diels-Alder reaction | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2005-10-25 | — | — | US | disclosed |
| US-20040059101-A1 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by diels-alder reaction | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) | 2004-03-25 | — | — | US | disclosed |
| EP-1313750-A1 | METHOD FOR PRODUCING WATER-SOLUBLE SACCHARIDE CONJUGATES AND SACCHARIDE MIMETICS BY DIELS-ALDER REACTION | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2003-05-28 | — | — | EP | disclosed |
| WO-2002016378-A1 | METHOD FOR PRODUCING WATER-SOLUBLE SACCHARIDE CONJUGATES AND SACCHARIDE MIMETICS BY DIELS-ALDER REACTION | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2002-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040059101-A1 | Method for producing water-soluble saccharide conjugates and saccharide mimetics by diels-alder reaction | SI, MAN1B1, SORD | EPHX2 586/4885AKR1B1 76/4885SLC5A2 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.